Search filters

List of works by Daniela Di Paolo

A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A.

scientific article published on 4 January 2017

A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo

scientific article published on 8 April 2016

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.

scientific article published on 29 December 2015

Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides

scientific article published on 7 May 2009

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma

scientific article published on 24 March 2010

Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis

scientific article

Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis

scientific article published on August 2006

Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma

scientific article published on 19 June 2013

Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin

scientific article

Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles

scientific article published on 07 October 2018

Ligand-targeted liposomal therapies of neuroblastoma.

scientific article published on January 2007

Liposome-mediated therapy of neuroblastoma

scientific article published in January 2009

Nanocarrier-mediated targeting of tumor and tumor vascular cells improves uptake and penetration of drugs into neuroblastoma.

scientific article published on 05 August 2013

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.

scientific article

Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion

scientific article published on August 2015

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK.

scientific article published on 20 June 2015

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

scientific article

PHOX2B-mediated regulation of ALK expression: in vitro identification of a functional relationship between two genes involved in neuroblastoma

scientific article

Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3.

scientific article published on 8 January 2014

Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma

scientific article published on 9 August 2011

Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications

scientific article

Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer

scientific article published in 2018

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy

scientific article published on October 2006

The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.

scientific article published on 20 August 2015

The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response

scientific article

The use of the orthotopic model to validate antivascular therapies for cancer

scientific article published on January 1, 2011

Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma

scientific article published on 8 October 2010

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma

scientific article published on 29 May 2015

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib

scientific article